These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10210942)

  • 1. [Lipid metabolism and atherosclerosis risk in renal diseases in pediatric age].
    Ferrara P; Ruggiero A; Pulitanò S; Vacca P; Venuti L; Salvaggio E
    Minerva Pediatr; 1998 Dec; 50(12):513-8. PubMed ID: 10210942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia in renal disease.
    Mittman N; Avram MM
    Semin Nephrol; 1996 May; 16(3):202-13. PubMed ID: 8734463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension, atherosclerosis and kidney].
    Zuccalà A; Fiorenza S; Rapanà R; Santoro A
    G Ital Nefrol; 2005; 22 Suppl 31():S9-14. PubMed ID: 15786409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis?
    Wasilewska A; Narkiewicz M; Rutkowski B; Łysiak-Szydłowska W
    Med Sci Monit; 2003 Mar; 9(3):CR147-51. PubMed ID: 12640345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors].
    Boizel R
    Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid lowering therapy in atherosclerosis.
    Aikawa M; Libby P
    Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperlipidemia in human renal disease.
    D'Amico GD; Gentile MG
    Miner Electrolyte Metab; 1993; 19(3):196-204. PubMed ID: 8232107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid disturbances in the nephrotic syndrome].
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2003; 60(11):758-61. PubMed ID: 15058052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
    Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
    Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cardiovascular risk factors and complications before and after kidney transplantation.
    Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA
    Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R; Riesen W
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into lipid metabolism in chronic kidney disease: what are the practical implications?
    Kaysen GA
    Blood Purif; 2009; 27(1):86-91. PubMed ID: 19169024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
    Butani L
    Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease.
    Kasiske BL; O'Donnell MP; Schmitz PG; Keane WF
    Adv Nephrol Necker Hosp; 1991; 20():109-25. PubMed ID: 2063707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.